Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   

Living With Dementia

dementia care program1 - zilboorg1 - mood changes1 - encephalopathy-alcoholic10 - involuntary movements2 - sleep apnea1 - igf-11 - p-tau1 - general activity1 - dementia of lewy body1 - boissier de sauvages2 - missing person1 - early signs of dementia1 - cognitive changes1 - good sleep habits1 - memory robbing disease1 - normal aging1 - alzheimer2 - startle myoclonus1 - cognitive tests1 - dementia symptoms3 - mediterranean1 - hospice2 - schizophrenia1 - ruth sutherland1 - cholinesterase inhibitors1 - sanofi1 - hiv-infected1 - management of delirium1 - heart attack2 -